Back to results
US 9,333,253 B2Granted
Vaccines for inclusion body hepatitis
AssigneesUniversity of Saskatchewan, University of Guelph
InventorsSusantha Gomis, Suresh Kumar Tikoo, Davor Ojkic
Life of this patent
Estimating the term…
Abstract
A composition comprising an isolated fowl adenovirus (FAdV), wherein the FAdV is a strain selected from FAdV-2, FAdV-7, FAdv-8a, FAdV-8b, FAdV-8a/8b or FAdV-11 serotype strains; and a suitable carrier and methods for inducing protective immunity in a subject and/or its progeny.
Claims14
An immunogenic composition comprising:
- an immunogenic effective amount of an isolated live and/or killed fowl adenovirus (FAdV), wherein the FAdV is a strain selected from FAdV, x11a-like isolate 04-53357-119 deposited under Accession number 081210-01;
- FAdV8ab isolate 04-53357-74 deposited under Accession number 081210-02;
- FAdV-8a, strain TR-59 isolate 04-53357-125 deposited under Accession number 081210-03 and, FAdV11 isolate 06-58730 deposited under Accession number 081210-04 and an effective amount of an adjuvant selected from CpG digodeoxynucleotides, oil-in water emulsified adjuvant or oil-in water emulsified adjuvant with dimethyldioctadecylammonium bromide (DDA) immune-stimulant.
Dependencies are inferred from the claim text.